Xiaojing Shi
Affiliations: | University of Southern California, Los Angeles, CA, United States |
Google:
"Xiaojing Shi"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Cai M, Xu S, Jin Y, et al. (2023) hMOF induces cisplatin resistance of ovarian cancer by regulating the stability and expression of MDM2. Cell Death Discovery. 9: 179 |
Asmamaw MD, Shi XJ, Zhang LR, et al. (2022) A comprehensive review of SHP2 and its role in cancer. Cellular Oncology (Dordrecht). 45: 729-753 |
Cheng Q, Dai Z, Shi X, et al. (2021) Expanding the toolbox of exosome-based modulators of cell functions. Biomaterials. 277: 121129 |
Shi X, Zhang XN, Chen J, et al. (2020) A poly-ADP-ribose polymer-based antibody-drug conjugate. Chemical Science. 11: 9303-9308 |
Shi X, Zhang Y. (2020) A Humanized Antibody Inhibitor for Cathepsin L. Protein Science : a Publication of the Protein Society |
Cheng Q, Shi X, Zhang Y. (2020) Reprogramming Exosomes for Immunotherapy. Methods in Molecular Biology (Clifton, N.J.). 2097: 197-209 |
Shi X, Cheng Q, Hou T, et al. (2019) Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy. Molecular Therapy : the Journal of the American Society of Gene Therapy |
Shi X, Cheng Q, Zhang Y. (2019) Reprogramming Extracellular Vesicles with Engineered Proteins. Methods (San Diego, Calif.) |
Cheng Q, Shi X, Han M, et al. (2018) Reprogramming Exosomes as Nanoscale Controllers of Cellular Immunity. Journal of the American Chemical Society |
Lv Y, Song Y, Ni C, et al. (2018) Overexpression of Lymphocyte Antigen 6 Complex, Locus E in Gastric Cancer Promotes Cancer Cell Growth and Metastasis. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 45: 1219-1229 |